Debt-to-equity of BRAINSTORM CELL THERAPEUTICS INC. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
BRAINSTORM CELL THERAPEUTICS INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • BRAINSTORM CELL THERAPEUTICS INC. Debt-to-equity for the quarter ending 30 Sep 2025 was -132%, a 25% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

BRAINSTORM CELL THERAPEUTICS INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -132% +44% +25% 30 Sep 2025
Q2 2025 -137% +78% +36% 30 Jun 2025
Q1 2025 -153% +60% +28% 31 Mar 2025
Q4 2024 -156% +89% +36% 31 Dec 2024
Q3 2024 -176% +117% +40% 30 Sep 2024
Q2 2024 -215% +227% +51% 30 Jun 2024
Q1 2024 -213% -3620% -106% 31 Mar 2024
Q4 2023 -245% -466% -211% 31 Dec 2023
Q3 2023 -294% -396% -386% 30 Sep 2023
Q2 2023 -441% -504% -801% 30 Jun 2023
Q1 2023 3407% +3359% +6960% 31 Mar 2023
Q4 2022 221% +181% +456% 31 Dec 2022
Q3 2022 103% +63% +161% 30 Sep 2022
Q2 2022 63% +26% +72% 30 Jun 2022
Q1 2022 48% +7% +17% 31 Mar 2022
Q4 2021 40% -11% -22% 31 Dec 2021
Q3 2021 39% -95% -71% 30 Sep 2021
Q2 2021 37% +31057% 30 Jun 2021
Q1 2021 41% +426% 31 Mar 2021
Q4 2020 51% +302% 31 Dec 2020
Q3 2020 135% +903% 30 Sep 2020
Q2 2020 -31020% -31343% -9701% 30 Jun 2020
Q1 2020 -385% -490% -465% 31 Mar 2020
Q4 2019 -251% -326% -436% 31 Dec 2019
Q3 2019 -768% -839% -1185% 30 Sep 2019
Q2 2019 323% 30 Jun 2019
Q1 2019 105% 31 Mar 2019
Q4 2018 75% 31 Dec 2018
Q3 2018 71% 30 Sep 2018
Q4 2015 16% -24% -60% 31 Dec 2015
Q3 2015 19% -23% -55% 30 Sep 2015
Q2 2015 21% -27% -57% 30 Jun 2015
Q1 2015 23% -58% -72% 31 Mar 2015
Q4 2014 41% -8% -16% 31 Dec 2014
Q3 2014 42% +4% +9.2% 30 Sep 2014
Q2 2014 48% +12% +33% 30 Jun 2014
Q1 2014 80% +37% +85% 31 Mar 2014
Q4 2013 49% -9% -15% 31 Dec 2013
Q3 2013 39% -40% -51% 30 Sep 2013
Q2 2013 36% -70% -66% 30 Jun 2013
Q1 2013 43% -29% -40% 31 Mar 2013
Q4 2012 57% 31 Dec 2012
Q3 2012 79% 30 Sep 2012
Q2 2012 106% 30 Jun 2012
Q1 2012 72% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.